Alzheimer's disease (AD) is generally regarded as a degenerative disease, but many normal physiological processes are increased in AD patients. My research deals with proteins involved in three major physiological processes in the brain: cell growth and differentiation; maintaining the environment between neurons (the extra-cellular matrix); and the inflammatory response. The question is whether these proteins and physiological processes play a critical role in initiating the disease or whether they are increased as a result of the disease.
Dr. Stopa began his academic appointment at Brown University School of Medicine in 1993 and is presently a Professor (Research Scholar Track) in the Department of Pathology. Dr. Stopa is also the current Director of the Neuropathology Division at Rhode Island Hospital, one of Brown's seven affiliated hospitals. In addition, Professor Stopa oversees the Brown Brain Bank, which provides human tissue for purposes of basic and translational research for the Department of Neuroscience.
EDWARD STOPA, MD
Collaborators at other institutions:
Are you Edward Stopa? Click here to edit your research profile.